Roberts Capital Advisors LLC Purchases New Stake in Intuitive Surgical, Inc. $ISRG

Key Points

• Roberts Capital Advisors LLC has acquired a new position in Intuitive Surgical, purchasing 1,718 shares valued at approximately $851,000 in the first quarter.
• A majority of Intuitive Surgical's stock, 83.64%, is currently owned by institutional investors, reflecting strong institutional interest in the company.
• Recent analyst upgrades have raised Intuitive Surgical's price targets, with several firms indicating a positive outlook for the stock and an average price target of $595.95.

Roberts Capital Advisors LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,718 shares of the medical equipment provider's stock, valued at approximately $851,000.

Several other large investors also recently made changes to their positions in the business. Chilton Capital Management LLC boosted its position in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 43 shares during the period. Parvin Asset Management LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth about $26,000. Global Financial Private Client LLC boosted its holdings in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after acquiring an additional 38 shares during the period. Elite Financial Inc. purchased a new position in shares of Intuitive Surgical in the first quarter valued at $26,000. Finally, LFA Lugano Financial Advisors SA purchased a new stake in shares of Intuitive Surgical during the first quarter worth about $30,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Activity

In other news, EVP Myriam Curet sold 4,500 shares of the firm's stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Gary S. Guthart sold 2,800 shares of Intuitive Surgical stock in a transaction dated Monday, July 28th. The shares were sold at an average price of $495.24, for a total value of $1,386,672.00. Following the completion of the transaction, the insider directly owned 18,520 shares of the company's stock, valued at $9,171,844.80. This represents a 13.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,839 shares of company stock worth $7,896,972. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Up 0.2%

Shares of NASDAQ:ISRG traded up $1.0820 during trading on Wednesday, reaching $480.2820. 1,034,698 shares of the company traded hands, compared to its average volume of 1,986,143. The firm has a fifty day simple moving average of $506.84 and a 200 day simple moving average of $523.82. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The firm has a market cap of $172.17 billion, a P/E ratio of 66.98, a price-to-earnings-growth ratio of 5.04 and a beta of 1.59.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. During the same period in the prior year, the company earned $1.78 EPS. The business's quarterly revenue was up 21.4% compared to the same quarter last year. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent analyst reports. Citigroup restated a "buy" rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Wall Street Zen raised Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their price target for the company from $515.00 to $440.00 in a report on Monday, June 9th. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a report on Wednesday, July 23rd. Finally, Erste Group Bank reiterated a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.